National Institutes of Health Center for Scientific Review; Notice of Closed Meetings, 61066 [2019-24466]
Download as PDF
<![CDATA[
61066
Federal Register / Vol. 84, No. 218 / Tuesday, November 12, 2019 / Notices
Approval is withdrawn as of
December 12, 2019.
FOR FURTHER INFORMATION CONTACT:
Sana F. Hussain, Center for Biologics
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7301,
Silver Spring, MD 20993–0002, 240–
402–7911.
SUPPLEMENTARY INFORMATION:
Haemonetics Manufacturing, Inc., 400
Wood Rd., Braintree, MA 02184, has
requested that FDA withdraw approval
of ANDA BA 710497/0, pursuant to
§ 314.150(c) (21 CFR 314.150(c)),
because the drug is no longer being
marketed. By its request, Haemonetics
Manufacturing, Inc., has also waived its
opportunity for a hearing. Withdrawal
of approval of an application under
§ 314.150(c) is without prejudice to
refiling.
DATES:
Application No.
Proprietary name
ANDA BA 710497/0 ...
Anticoagulant Citrate Dextrose Solution A, USP
(ACD–A) In Plastic Bags.
Therefore, approval of the application
listed in the table, and all amendments
and supplements thereto, is hereby
withdrawn as of December 12, 2019.
Introduction or delivery for introduction
into interstate commerce for products
without an approved new drug
application or ANDA violates section
301(a) and (d) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 331(a) and
(d)). The drug product that is listed in
the table above that is in inventory on
December 12, 2019 may continue to be
dispensed until the inventory has been
depleted or the drug product has
reached its expiration date or otherwise
becomes violative, whichever occurs
first.
Dated: October 29, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–24527 Filed 11–8–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health Center for
Scientific Review; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
17:47 Nov 08, 2019
Jkt 250001
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Interventions and Mechanisms for
Addiction.
Date: December 2, 2019.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Marc Boulay, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
MSC 7808, Bethesda, MD 20892, (301) 300–
6541, boulaymg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Interactive Digital Media STEM Resources for
Pre-College and Informal Science Education
Audiences (SBIR/STTR).
Date: December 3, 2019.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Marie-Jose Belanger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 6188,
MSC 7804, Bethesda, MD 20892, 301–435–
1267, belangerm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Lasker
Clinical Research Scholars Program (Si2/R00
Clinical Trial Optional).
Date: December 3, 2019.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Abdelouahab Aitouche,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4222,
MSC 7814, Bethesda, MD 20892, 301–435–
2365, aitouchea@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurodevelopmental and Neurodegenerative
Disorders.
Date: December 3, 2019.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 4, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–24466 Filed 11–8–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[Docket No. USCBP–2019–0042]
Commercial Customs Operations
Advisory Committee (COAC)
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security (DHS).
ACTION: Committee Management; Notice
of Federal Advisory Committee Meeting.
AGENCY:
The Commercial Customs
Operations Advisory Committee (COAC)
will hold its quarterly meeting on
Wednesday, December 4, 2019, in
Washington, DC. The meeting will be
open to the public to attend either in
person or via webinar.
DATES: The COAC will meet on
Wednesday, December 4, 2019, from
1:00 p.m. to 5:00 p.m. EST. Please note
that the meeting may close early if the
committee has completed its business.
Comments must be submitted in writing
no later than December 3, 2019.
ADDRESSES: The meeting will be held at
the Ronald Reagan Building,
International Trade Center-Horizon
Ballroom, 1300 Pennsylvania Ave. NW,
Washington, DC 20229. For information
on facilities or services for individuals
with disabilities or to request special
assistance at the meeting, contact Ms.
Florence Constant-Gibson, Office of
Trade Relations, U.S. Customs and
Border Protection (CBP), at (202) 344–
1440 as soon as possible.
FOR FURTHER INFORMATION CONTACT: Ms.
Florence Constant-Gibson, Office of
Trade Relations, U.S. Customs and
Border Protection, 1300 Pennsylvania
Avenue NW, Room 3.5A, Washington,
DC 20229; telephone (202) 344–1440;
facsimile (202) 325–4290; or Ms. Valarie
M. Neuhart, Acting Executive Director
SUMMARY:
E:\FR\FM\12NON1.SGM
12NON1
]]>Agencies
[Federal Register Volume 84, Number 218 (Tuesday, November 12, 2019)]
[Notices]
[Page 61066]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24466]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Center for Scientific Review;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Interventions and Mechanisms for Addiction.
Date: December 2, 2019.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Marc Boulay, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 20892, (301) 300-
6541, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Interactive Digital Media STEM Resources for Pre-
College and Informal Science Education Audiences (SBIR/STTR).
Date: December 3, 2019.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Marie-Jose Belanger, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 6188, MSC 7804, Bethesda, MD
20892, 301-435-1267, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Lasker Clinical Research Scholars Program (Si2/R00 Clinical
Trial Optional).
Date: December 3, 2019.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Abdelouahab Aitouche, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD
20892, 301-435-2365, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neurodevelopmental and Neurodegenerative Disorders.
Date: December 3, 2019.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: November 4, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-24466 Filed 11-8-19; 8:45 am]
BILLING CODE 4140-01-P
